115 related articles for article (PubMed ID: 35970794)
1. [Expression of miR-17-5p in the plasma of patients with multiple myeloma and its role in tumorigenesis and development].
Xiang P; Liu LN; Liu YZ; Cui YS; Fang BJ
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(30):2357-2362. PubMed ID: 35970794
[No Abstract] [Full Text] [Related]
2. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
Yang S; Wang W; Jin H; Zhong Y; Xie X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):371-378. PubMed ID: 27868410
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Li J; Zhang M; Wang C
J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
[TBL] [Abstract][Full Text] [Related]
4. [MiR-203a-5p Inhibits Multiple Myeloma Cell Proliferation and Cell Cycle Progression via Targeting
Zhang Y; Chen TT; Zhou HB; Chen WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):801-809. PubMed ID: 37356943
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
Wu K; Wang L; Fu G; Zheng Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in urine as diagnostic biomarkers for multiple myeloma.
Li J; Wang C; Meng Q; Hu Z; Hu M; Zhang M
Int J Lab Hematol; 2021 Apr; 43(2):227-234. PubMed ID: 33068078
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.
Qu X; Zhao M; Wu S; Yu W; Xu J; Xu J; Li J; Chen L
Med Oncol; 2014 Oct; 31(10):219. PubMed ID: 25216866
[TBL] [Abstract][Full Text] [Related]
10. [Value of serum miR-155-5p and miR-133a-3p expression for the diagnosis and prognosis evaluation of sepsis].
Lan C; Shi X; Guo N; Pei H; Zhang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):694-8. PubMed ID: 27434558
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of plasma microRNA-30b-5p combined with extravascular lung water index in patients with acute respiratory distress syndrome].
Li C; Tan M; Wang S; Cai X; Li X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):570-574. PubMed ID: 32576349
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
13. miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition.
Xiang P; Yeung YT; Wang J; Wu Q; Du R; Huang C; Jia X; Gao Y; Zhi Y; Guo F; Wei H; Zhang D; Liu Y; Liu L; Liang L; Wang J; Song Y; Liu K; Fang B
Int J Cancer; 2021 Jun; 148(12):3071-3085. PubMed ID: 33609405
[TBL] [Abstract][Full Text] [Related]
14. The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma.
Xiang P; Liu Y; Liu L; Lin Q; Liu X; Zhang H; Xu J; Fang B
Acta Haematol; 2019; 142(4):208-216. PubMed ID: 31163428
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.
Chen L; Hu N; Wang C; Zhao H; Gu Y
Cell Cycle; 2018; 17(3):319-329. PubMed ID: 29228867
[TBL] [Abstract][Full Text] [Related]
16. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
[TBL] [Abstract][Full Text] [Related]
17. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
18. High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.
Steiner N; Hajek R; Sevcikova S; Borjan B; Jöhrer K; Göbel G; Untergasser G; Gunsilius E
PLoS One; 2017; 12(7):e0181487. PubMed ID: 28727816
[TBL] [Abstract][Full Text] [Related]
19. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
20. [Hsa_circ_0000670 promoted the progression of gastric cancer through the miR-515-5p/SIX1 molecular axis].
Gu H; Ruan RJ; Lu XD; Chu XF
Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):238-252. PubMed ID: 36944545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
